How Drugs are Reviewed in Canada

Health Canada's drug products fact sheet describes how drugs are reviewed in Canada including how drugs are developed and submitted for authorization to conduct clinical trial.

Data and Resources

Additional Info

Field Value
Source
Version None
Author None
Author Email None
Maintainer None
Maintainer Email None
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Comment les médicaments sont examinés au Canada
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2017-05-18 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["examen des médicaments", "évaluation prioritaire", "médicaments pouvant sauver des vies", "examen accéléré", "autorisation pour mener des essais cliniques"], "en": ["Drug review", "priority review", "fast-track", "life-saving drugs", "expedited", "and authorization for clinical trial."]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source